Ceftriaxone Injection Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder/ Prefilled syringe
Available Strengths: 250 mg, 1 g, and 2 g
Reference Brands: Rocephin
Category:
Active Pharmaceutical Ingredient
Ceftriaxone API inhibits bacterial cell wall synthesis by blocking peptidoglycan cross-linking, leading to bacterial death. It treats a wide range of systemic infections, including pneumonia and meningitis. Benefits include high efficacy, broad-spectrum activity, and convenient dosing, supporting effective antimicrobial therapy and improved patient outcomes worldwide.
Ceftriaxone Injection is available in Lyophilized powder/ Prefilled syringe
and strengths such as 250 mg, 1 g, and 2 g.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ceftriaxone Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ceftriaxone Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ceftriaxone injectable API is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves clinical validation, safety assessments, and GMP compliance, while in the EU, CE marking certifies conformity with MDR standards. These APIs undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to high-quality ceftriaxone APIs vital for treating systemic bacterial infections worldwide, supporting effective antimicrobial therapy and patient care.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing